Viewing data from:

ABACAVIR SULFATE AND LAMIVUDINE

ANDA

ABACAVIR SULFATE; LAMIVUDINE | A204990 | CHARTWELL RX SCIENCES LLC

1 strength0 unique patents0 unique exclusivities

Approval Letters

2 letters from Drugs@FDA

Date	Submission	Document
Mar 30, 2017	ORIG -1	View Letter (PDF)
Nov 22, 2016	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (1)

#001 — EQ 600MG BASE;300MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Mar 28, 2017

No patent or exclusivity listings for this strength.